Compound ID | 1271
AKAO-LpxC
Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)
| Spectrum of activity: | Gram-negative |
| Details of activity: | P. aeruginosa infections. |
| Institute where first reported: | Achaogen |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Toxicity of the compound |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.